Self-ligating brackets group
|
0
|
23
|
28
|
W= 153.06 P=0.001
|
W= 97.53 P=0.001
|
NS
|
Conventional brackets group
|
0
|
33
|
37 **
|
W= 133.06 P=0.001
|
W= 178.0 P=0.001
|
NS
|
Control group
|
0
|
14 **
|
27
|
W= 127.88 P=0.001
|
W= 188.0 P=0.001
|
NS
|
|
Buffering capacity (indicated as the more frequent nominal value for each group)
|
Self-ligating group VERSUS Control group
|
Conventional group VERSUS Control group
|
Self-ligating group VERSUS Cnventional group
|
Self-ligating brackets group
|
3 (middle boffering capacity)
| | |
NS
|
Conventional brackets group
|
4 (middle-high capacity)
|
NS
| | |
Control group
|
3 (middle capacity)
| |
NS
| |
|
Salivary Flow (T0)
|
Salivary Flow (T1)
|
Salivary Flow (T2)
|
T0 versus T1
|
T0 versus T2
|
T1 versus T2
|
Self-ligating brackets group
|
59
|
69
|
69
|
W= 10.7 P=0.05
|
W= 97.53 P=0.001
|
NS
|
Conventional brackets group
|
51
|
59
|
59
|
NS
|
NS
|
NS
|
Control group
|
50
|
50 **
|
50 *
|
NS
|
NS
|
NS
|
|
% of subjects with abnormal value (>10
5
) T0
|
% of subjects with abnormal value (>10
5
) T1
|
% of subjects with abnormal value (>10
5
) T2
|
T0 versus T1
|
T0 versus T2
|
T1 versus T2
|
Self-ligating brackets group
|
0%
|
25%
|
45%
|
NS
|
Chi-square= 10.17 P= 0.01
|
NS
|
Conventional brackets group
|
0%
|
60% **
|
20% **
|
Chi-square = 97.53 P=0.001
|
Chi-square= 24.47 P= 0.001
|
Chi-square= 88.6 P=0.001
|
Control group
|
0%
|
5%
|
35%
|
NS
|
Chi-square= 10.75 p=0.001
|
Chi-square= 14.25 P=0.01
|
|
% of subjects with abnormal value (>10
5
) T0
|
% of subjects with abnormal value (>10
5
) T1
|
% of subjects with abnormal value (>10
5
) T2
|
T0 versus T1
|
T0 versus T2
|
T1 versus T2
|
Self-ligating brackets group
|
0%
|
10%
|
25%
|
Chi-square=5 P=0.03
|
Chi-square=4.27 P=0.04
|
Chi-square=27.22 P=0.001
|
Conventional brackets group
|
0%
|
50%
|
70%
|
Chi-square=35.5 P=0.001
|
Chi-square=80 P=0.001
|
NS
|
Control group
|
0%
|
10%
|
30%
|
NS
|
Chi-square=8.8 P=0.001
|
Chi-square=8.8 P=0.001
|